NCT06054217View on ClinicalTrials.gov

Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

June 15, 2024

Study Completion Date

June 15, 2024

Conditions
Meibomian Gland DysfunctionDemodex Infestation of EyelidBlepharitisDemodectic Blepharitis
Interventions
DRUG

Vehicle of TP-03

The Exploratory Vehicle is the vehicle of TP-03 (lotilaner ophthalmic solution, 0.25%)

Trial Locations (2)

28150

Vita Eye Clinic, Shelby

91325

Shultz Chang Vision, Northridge

All Listed Sponsors
lead

Tarsus Pharmaceuticals, Inc.

INDUSTRY